Advertisement

Nanoscale Research Letters

, 14:26 | Cite as

Exposure to Titanium Dioxide Nanoparticles During Pregnancy Changed Maternal Gut Microbiota and Increased Blood Glucose of Rat

  • Zhilei Mao
  • Yaqi Li
  • Tianyu Dong
  • Lina Zhang
  • Yuqing Zhang
  • Shushu Li
  • Haiting Hu
  • Caifeng SunEmail author
  • Yankai XiaEmail author
Open Access
Nano Express

Abstract

Titanium dioxide nanoparticles (TiO2 NPs) were used worldwide for decades, and pregnant women are unable to avoid exposing to them. Studies revealed that TiO2 NPs could kill many kinds of bacteria, but whether they would affect the composition of gut microbiota, especially during pregnancy, was seldom reported. And, what adverse effects may be brought to pregnant females was also unknown. In this study, we established the prenatal exposure model of rats to explore the effects of TiO2 NPs on gut microbiota. We observed an increasing trend, but not a significant change of alpha-diversity among control and exposure groups at gestation day (GD) 10 and GD 17 during normal pregnancy process. Each different time point had unique gut microbiota operational taxonomic units (OTUs) characteristics. The abundance of Ellin6075 decreased at GD 10 and GD 17, Clostridiales increased at GD 10, and Dehalobacteriaceae decreased at GD 17 after TiO2 NPs exposure. Further phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) prediction indicated that the type 2 diabetes mellitus related genes were enhanced, and taurine metabolism was weakened at the second-trimester. Further study showed that the rats’ fasting blood glucose levels significantly increased at GD 10 (P < 0.05) and GD 17 (P < 0.01) after exposure. Our study pointed out that TiO2 NPs induced the alteration of gut microbiota during pregnancy and increased the fasting blood glucose of pregnant rats, which might increase the potential risk of gestational diabetes of pregnant women.

Keywords

TiO2 NPs Gut microbiota Pregnancy exposure Increased fasting blood glucose 

Abbreviations

DLS

Dynamic light scattering

GD

Gestation day

LDA

Linear discriminant analysis

NMDS

Non-metric multi-dimensional scaling

OGTT

Oral glucose tolerance test

OTUs

Operational taxonomic units

PICRUSt

Phylogenetic investigation of communities by reconstruction of unobserved states

QIIME

Quantitative insights into microbial ecology

SD

Sprague-Dawley

TiO2 NPs

Titanium dioxide nanoparticles

Introduction

Titanium dioxide nanoparticle (TiO2 NP) is one of the most widely used nanomaterial, and can be easily found in sunscreen, paint, ink, and foods [1, 2]. They can easily be released and enter human body during the usage of commercial products. Notably, the pregnant women cannot avoid exposing to them. Animal studies had shown that the ovarian and reproductive system dysfunction were observed [3], and monoaminergic neurotransmitters were also impaired [4] when adult female mice were exposed to TiO2 NPs. Further, pregnancy complications and adverse birth outcomes were also observed after pregnant mice exposed to TiO2 NPs [5]. All studies above indicated that TiO2 NPs were harmful to adult female animals, as well as the pregnant females, but the mechanisms were not fully understood. So the relative studies need to be carried out for the safety evaluation of TiO2 NPs.

TiO2 NP is used as a kind of powerful antibacterial agent; they can kill many types of bacteria, including Staphylococcus aureus, Salmonella, Streptococcus mutans, and so on [6]. The antibacterial effects were nonselective actually, while most of the current studies mainly focus on their effects on killing harmful bacteria, few reported whether TiO2 NPs would kill probiotics or other symbiotic bacteria and bring adverse effects to human beings. Studies about whether TiO2 NPs would change normal composition of gut microbiota and cause disadvantages to pregnant females were also lacking; therefore, we carried out this study from the perspective of gut microbiota.

Recently, more and more researches showed that gut microbiota were closely related with human disease including type 2 diabetes [7] and obesity [8]. Probiotics could affect the metabolic of pregnant women with gestational diabetes [9], and change the methylation of diabetes-associated genes in fetuses [10]. Studies reported that the plasma glucose level increased when adult mice were exposed to TiO2 NPs for 12 weeks [11]. Whether the blood glucose of pregnant females would increase after exposure and whether the exposure period would shorten were not reported.

All the studies mentioned above suggested that TiO2 NPs may affect gut microbiota and increase the plasma glucose level, but no direct evidence proved the linkage between gut microbiota and maternal blood glucose level, and the mechanisms were also not clear. Previous studies mainly focus on adult animal studies, and the effects of TiO2 NPs on pregnant females were merely studied from the perspective of gut microbiota. In this study, we established the pregnancy exposure model of rat to explore whether the maternal gut microbiota would change and how they change after the pregnant females exposed to TiO2 NPs, and we tried to answer the issue that what adverse effects would be brought to the pregnant females by gut microbiota changes after TiO2 NPs exposure. Our study raised the concerns about the safety of TiO2 NPs to the pregnant women and we revealed the potential mechanisms.

Materials and Methods

Study Design

On the basis of a study carried out by Weir, A. and his colleagues in human beings [12], the exposure route and exposure dose in rats were determined. The female rats were daily gavage administrated with 5 mg/kg bw/day of TiO2 NPs from the 5th to 18th day after pregnancy, and the progress was shown in Fig. 1a. Each rat was weighed before oral exposure, and 0.5% of the methylcellulose was given as vehicle control.
Fig. 1

a The experimental design of this study. b The TEM images of TiO2 NPs, bar = 50 nm. c Main characteristics of TiO2 NPs measured or reported by manufacturer were presented

Animals

Animal studies were performed with the permission of the ethics committee. Sprague-Dawley (SD) rats were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. Female rats (n = 8, 12 weeks old) were separated from male rats (n = 8, 14 weeks old), and rats of the same gender were kept in a large cage. All rats were housed in a temperature- (22 ± 2 °C) and humidity-controlled (40–60%) condition, with a 12 h light/dark cycle for 1 week rest. Then the female rats were randomly divided into control group (n = 4) and exposure group (n = 4), and mated with males at a 1:1 ratio in individual cages. Vaginal plug were observed every morning and the presence of vaginal plug confirmed pregnancy and recorded as gestation day 0.5 (GD 0.5), and the pregnant rats were raised in separated cages.

TiO2 NPs Preparation and Administration

TiO2 NP is a commercial product purchased from Sigma-Aldrich (13463-67-7). The stock solution of TiO2 NPs were dissolved in methylcellulose (0.5%) at the concentration of 5 mg/ml according to a previous study [13], and sonicated for 30 min (100 W). The hydrodynamic diameter of TiO2 NPs in methylcellulose was measured with dynamic light scattering (DLS).

Feces Collection and Fecal Total DNA Preparation

The feces of each rat were collected at GD 0 (before mating), GD 10, and GD 17 with the process of pregnancy, respectively. The feces were stored at − 80 °C before bacterial diversity were analyzed. Fecal total DNA was extracted using a Power Soil DNA kit (Mo Bio Laboratories, Carlsbad, California, USA) according to the manufacturer’s protocol. And the DNA concentrations were measured by NanoDrop spectrophotometer (NanoDrop™ 2000/2000C, USA).

16S rRNA Gene Sequencing and Data Analysis

Bacterial sequencing of 16S rRNA genes was performed with the Illumina MiSeq platform (Hangzhou Guhe Information and Technology Co., Ltd., Zhejiang, China). The V3 and V4 regions of bacterial 16S rRNA were amplified with specific primers as previously described [14]. And the DNAs were subjected for Illumina MiSeq sequencing after amplified and purified. The sequencing data were processed using quantitative insights into microbial ecology (QIIME) according to previous studies [15]. Data was read and merged from original DNA fragments, and the read lengths were between 400 and 500 bp. Chimeric sequences was further examined using QIIME if occurs.

Blood Sample Collection and Blood Glucose Determination

The fasting venous blood of all female rats was also collected accordingly when feces were collected. The blood samples were collected from caudal vein in the morning after 12 h of starvation at GD 0, GD 10, and GD 17, respectively. Then the fasting blood glucose levels were immediately determined with Roche ACCU-CHEK® Performa meter according to the manufacturer’s protocol after collection.

Statistical Analysis

Statistical analysis were performed with Graphpad Prism 6; all data about the diversity of bacterium were presented with box plots as Mean ± SE, and significance of among all groups were examined by one-way ANOVA followed by Dunnett’s multiple comparison test. P < 0.05 was considered as statistically significant.

Results and Discussion

Characteristics of TiO2 NPs

The main characteristics of TiO2 NPs were measured and presented before animal studies. Figure 1b showed a visual field of TiO2 NPs under transmission electronic microscope. The morphology of TiO2 NPs was nearly sphere with a primary diameter of about 21 nm. The average hydrodynamic diameter was about 199.5 nm in methylcellulose solution (Fig. 1c). The purity of TiO2 NPs is  99.5%, and the surface area is 35–65 m2/g according to the manufacturer’s report. Recent studies reported that both nano- and fine grade TiO2 could increase the blood glucose level of adult animals after oral exposure [11, 16], and whether the blood glucose of the pregnant females would be affected was unknown. To make this question and underlying mechanisms clear, we established the pregnancy rat exposure model to evaluate the toxicity of TiO2 NPs and to probe the harms to pregnant rats.

Most TiO2 particles in products are with primary size of mainly ranging from 60 to 300 nm, minority (~ 20%) was < 100 nm [17], while recent study showed that the amount of TiO2 NPs in some food products is much larger than we known (~ 90%), for instance, chewing gum [18]. As known, smaller nanoparticles had higher toxicity [19, 20], and the females were more sensitive to harmful substrates during pregnancy, so the minority part of TiO2 NPs may bring nonnegligible effects to pregnant females than the majority fine particles. In this study, we exposed the pregnant rat model to nanosized TiO2 (~ 21 nm) to study the potential risks of TiO2 NPs to pregnant women.

Bacteria Diversity Changes During Normal Pregnancy

During gestation, pregnant females become more sensitive to physical and chemical exposure; in order to decrease the effects of manual operation to the implantation of fertilized egg, the 5th day was chosen as the first day of exposure when the blastulas had finished implantation. GD 17 is the last day before delivery and GD 10 is the midterm of pregnancy. The normal dynamics of gut microbiome during pregnancy was examined using fecal samples from three time points of control groups (GD 0, GD 10, and GD 17). We observed the alpha-diversity of gut microbiome over time by computing Shannon, Simpson, and Chao1 indexes, but the difference was not significant (Fig. 2a). Based on non-metric multi-dimensional scaling (NMDS) analysis, no marked difference was also found in samples from different time points (Fig. 2b), which was consistent with previous studies [21, 22]. The Venn diagram (Fig. 2c) showed the shared and specific operational taxonomic units (OTUs) in samples of different time points, and the shared OTUs of three time points (GD 0, GD 10, GD 17) in control groups was 164; these results indicated that the number of specific OTUs was increased with time during pregnancy. Our results showed that the gut microbiota revealed no significant change during normal pregnancy, and the changes will not bring adverse effects and are even beneficial to maternal. Our results suggested that the gut microbiota change might be the result of pregnancy process, which might be caused by hormonal changes of pregnant females [23], similar as vaginal flora changes during pregnancy [24]. Also, it might be a precondition for normal pregnancy.
Fig. 2

Changes in the characteristics of gut microbiota in control (unexposed) rats in the course of a normal pregnancy. a Alpha-diversity of gut microbiome revealed by Shannon, Simpson, and Chao1 index. b The beta-diversity was revealed by non-metric multi-dimensional scaling (NMDS) analysis. c The unique and sharing operational taxonomic units (OTUs) numbers were presented in Venn diagram. D0 Ctrl means rats in control group before mating, d10 Ctrl and d17 Ctrl means the control rats in GD 10 and GD 17, respectively

Bacteria Diversity Changes After Exposed to TiO2 NPs During Pregnancy

Studies indicated that gut microbiota is crucial for the maintenance of normal immunity situation [25]; a natural change of gut microbiota during normal pregnancy may regulate the immunity system to accept the implantation of fertilized eggs [26]. Meanwhile, the natural alteration of gut microbiota during normal pregnancy might also help the pregnant women adapt to the metabolic changes during gestation. Once the alteration of gut microbiota exceeded a “proper degree,” adverse pregnancy outcome may be brought. So we analyzed the microbiota changes after TiO2 NPs exposure in the following part. The effects of TiO2 NPs on bacteria diversity during pregnancy were evaluated by analyzing alpha-diversity and beta-diversity at GD 0, GD10, and GD17 after females were exposed to nanoparticles. The results showed that the alpha-diversity showed an increasing trend in Shannon, and a significant change in Simpson index (P < 0.05) when comparing to normal pregnancy, but no difference in Chao1 (Fig. 3a). The NMDS analysis (Fig. 3b) also showed no significant difference as it is in normal pregnancy, but after exposure to TiO2 NPs, the specific OTUs in samples decreased at middle and late pregnancy (Fig. 3c). During normal pregnancy, the diversity of gut microbiota had no obvious change, but we observed an increasing trend of bacteria diversity in maternal feces after female mice were exposed to TiO2 NPs during pregnancy, which might be due to TiO2 NPs being a highly efficient antibacterial agent, and could kill many kinds of bacteria; they inhibited the dominant bacteria in gut and the originally suppressed bacteria could reproduce under this condition. Studies indicated that gut microbiota was associated with many diseases, including diabetes, obesity, hypertension [27], and cancer [28]; the linkage between gut microbiota and gestational diabetes had also been confirmed [29]. The reason why no significant change among GD 0, GD10, and GD17 was observed after exposure may be that TiO2 NPs was “relatively safe” or the microbiota changes induced by TiO2 NPs exposure may be covered by the pregnant-related microbiota changes.
Fig. 3

Changes in the characteristics of gut microbiota in exposed rats in the course of pregnancy. a The alpha-diversity of gut microbiome revealed by Shannon, Simpson, and Chao1 index. b The beta-diversity was revealed by NMDS analysis. c The unique and sharing OTUs numbers were presented in Venn diagram. D0 Test means samples collected from rats before exposure to TiO2 NPs, d10 Test, and d17 Test means samples collected from exposed rats at GD 10 and GD 17, respectively

Gut Microbiota Changes in Second Trimester After Exposed to TiO2 NPs

To exclude the effects of pregnancy and further find out the independent effects of TiO2 NPs on gut microbiota, we compared the differences of gut microbiome between control group and treatment group using samples collected from second trimester (GD 10). No significant difference of alpha-diversity was found according to Shannon, Simpson, and Chao1 indexes (Fig. 4a). A remarkable distinction was observed between the two groups based on NMDS analysis (Fig. 4b). Figure 4c showed that exposure of TiO2 NPs led to the changes of some specific OTUs in treatment group compared with the control (Venn). These results showed that TiO2 NPs were relatively safe and will not induce obvious dysbacteriosis. But the flora composition, namely the abundance of specific genus, changed in the second trimester and late pregnancy stage respectively. To further find out the potential risks of the changes that happed during pregnancy and explore what adverse effects may be brought, we identified the functional changes of the gut microbiota with bioinformatics. The results showed that two dominant biomarkers, Ellin6075 and Clostridiales, were found by LefSe analysis (linear discriminant analysis (LDA) > 2). Abundance of Ellin6075 was decreased and Clostridiales was increased after TiO2 NPs exposure respectively (Fig. 4d). Ellin6075 was isolated from an Australia farm, but little information was available regarding its phenotypic traits or functions, so their effects on pregnancy need further investigation. Yan and his colleagues showed that Clostridium significantly increased in obesity SD rats [30], which were consistent with our finding that Clostridiales co-existed with high level of blood glucose. To reveal the effects of gut microbiota change on pregnancy, we predicted the gene differences in fecal samples using phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) (Fig. 4e), and found that genes about type 2 diabetes mellitus related function and lipid biosynthesis proteins were strengthened in treatment group, while taurine and hypotaurine metabolism was weakened. Researchers had demonstrated that gut microbiota could generate short-chain fatty acid, including acetic acid, propionic acid, and regulate the host blood glucose in turn [31]. And the change of taurine and hypotaurine were also in accordance with the fact that taurine could downregulate the maternal blood glucose concentrations [32].
Fig. 4

Changes in the characteristics of gut microbiota between control rats and TiO2 NP exposed rats at GD 10. a, b Alpha- and beta-diversity of gut microbiome were presented as Shannon, Simpson, and Chao1 index, as well as NMDS analysis. c Venn diagram showed the OTUs characteristics. d, e Dominant biomarkers and related gene functions were found by Lefse and phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) prediction, respectively. D10 Ctrl means the control rats at GD 10, d10 Test means the exposure rats in GD 10

Gut Microbiota Changes in Late Pregnancy After Exposed to TiO2 NPs

Gut microbiome of late pregnancy was examined by fecal samples collected at GD17. No significant difference was found in alpha-diversity (Fig. 5a). These samples were districted significantly by control and treatment group in the NMDS model (Fig. 5b). As shown in Fig. 5c, decreased number of observed OTUs was found in the treatment group. We also used Lefse to identify potential biomarkers. Notably, as shown in Fig. 5d, abundance of Ellin6075 persisted decreased in the treatment group during late pregnancy (LDA > 2), and the abundance of Dehalobacteriaceae was decreased by exposure to TiO2 NPs as well (LDA > 2). In this stage, the diabetes mellitus-related gene changes was not observed, which suggested that the second trimester, instead of the late trimester, was the sensitive window for TiO2 NPs to increase the maternal blood glucose. And the result was in agreement with our clinical recognition that, our doctors carried out the oral glucose tolerance test (OGTT), a common diagnosis of human gestational diabetes, to screen gestational diabetes in pregnant women at the second-trimester (about 26th week in pregnant women). The results showed that the fasting blood glucose had increased on GD 10 after the pregnant rats exposed to TiO2 NPs, and is prior to a previous result reported (~ 12 weeks) in adult animals [11], which proved the fact that pregnant females were more sensitive than adults.
Fig. 5

Changes in the characteristics of gut microbiota between control rats and TiO2 NP exposed rats at GD 17. a Shannon, Simpson, and Chao1 index which presented alpha-diversity were compared between two groups. b The beta-diversity was revealed by NMDS analysis. c The Venn diagram showing the unique and sharing OTUs in two groups. d Lefse found the candidate biomarkers (LDA > 2) and the differences of gene functions were predicted. e The fasting blood glucose levels of rats were measured at GD 0, GD 10, and GD 17 after exposed to TiO2 NPs. D17 Ctrl and d17 Test means the control and exposed rats on the 17th day of pregnancy, respectively

The Effects of TiO2 NPs on Blood Glucose After Prenatal Exposure

In order to prove the results of PICRUSt prediction, we measured the rats’ fasting blood glucose at GD10 and GD17, respectively. After the pregnant rats were exposed to TiO2 NPs for 12 days (GD5–GD17), the fasting blood glucose levels were measured. As shown in Fig. 5e, comparing with control group, the rats’ fasting glucose levels increased significantly at both GD10 (P < 0.05) and GD17 (P < 0.01) after exposed to TiO2 NPs, which was in accordance with the previous reports that TiO2 NPs could increase the blood glucose level of adult animals [11, 33]. But the increment of value between control group and GD 17 was relatively small (~ 0.5 mM), and did not reach the standard of gestational diabetes [34]. The results suggested that, maternal solitary exposed to TiO2 NPs during pregnant is not sufficient to induce gestational diabetes, but the increased blood glucose may bring adverse effects to the pregnant females and their offspring. And it was reported that maternal exposed to higher blood glucose during pregnancy might increase the risks of obesity and abnormal glucose tolerance of fetuses [35], which also reminded us that TiO2 NPs may bring potential risks to offspring.

Conclusion

Our studies indicated that prenatal exposure of TiO2 NPs could increase maternal fasting blood glucose levels, and the gut microbiota alterations might be the underlying mechanism. And we draw the conclusion that TiO2 NPs might increase the risk of gestational diabetes of human pregnant women, which should arouse our attentions.

Notes

Acknowledgement

We thank the Hangzhou Guhe Information and Technology Company for bacterial sequencing and data analysis.

Funding

This study was supported by National Natural Science Fund of China (81703256); Jiangsu Provincial Medical Youth Talent (QNRC2016307); Young Medical Talents of Changzhou (QN201504); The Open Project of The Key Laboratory of Modern Toxicology of Ministry of Education, Nanjing Medical University (NMUAMT201803); National Science Fund for Outstanding Young Scholars (81322039).

Availability of Data and Materials

The datasets used for analysis can be provided on a suitable request, by the corresponding author.

Authors’ Contributions

ZM designed this study and wrote the manuscript, YL and SL raised the animals and collected the testing samples, TD was responsible for the data checking and analysis, LZ contributed to figure modifying, YZ and HH helped for grammar revising and language checking, and CS helped in the linguistic errors checking and sentences modifying. All authors read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Nanjing Medical University, and all treatments abided by the ethics committee's standard.

Competing Interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.
    Grande F, Tucci P (2016) Titanium dioxide nanoparticles: a risk for human health? Mini Rev Med Chem 16:762–769CrossRefGoogle Scholar
  2. 2.
    Peters RJ, van Bemmel G, Herrera-Rivera Z et al (2014) Characterization of titanium dioxide nanoparticles in food products: analytical methods to define nanoparticles. J Agric Food Chem 62:6285–6293CrossRefGoogle Scholar
  3. 3.
    Gao G, Ze Y, Li B et al (2012) Ovarian dysfunction and gene-expressed characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles. J Hazard Mater 243:19–27CrossRefGoogle Scholar
  4. 4.
    Wang JX, Li YF, Zhou GQ et al (2007) Influence of intranasal instilled titanium dioxide nanoparticles on monoaminergic neurotransmitters of female mice at different exposure time. Zhonghua Yu Fang Yi Xue Za Zhi 41:91–95Google Scholar
  5. 5.
    Yamashita K, Yoshioka Y, Higashisaka K et al (2011) Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 6:321–328CrossRefGoogle Scholar
  6. 6.
    Tsuang YH, Sun JS, Huang YC et al (2008) Studies of photokilling of bacteria using titanium dioxide nanoparticles. Artif Organs 32:167–174CrossRefGoogle Scholar
  7. 7.
    Navab-Moghadam F, Sedighi M, Khamseh ME et al (2017) The association of type II diabetes with gut microbiota composition. Microb Pathog 110:630–636CrossRefGoogle Scholar
  8. 8.
    Li J, Riaz Rajoka MS, Shao D et al (2017) Strategies to increase the efficacy of using gut microbiota for the modulation of obesity. Obes Rev 18(11):1260–1271CrossRefGoogle Scholar
  9. 9.
    Taylor BL, Woodfall GE, Sheedy KE et al (2017) Effect of probiotics on metabolic outcomes in pregnant women with gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutrients 9(5).  https://doi.org/10.3390/nu9050461
  10. 10.
    Tachibana K, Sakurai K, Watanabe M et al (2017) Associations between changes in the maternal gut microbiome and differentially methylated regions of diabetes-associated genes in fetuses: a pilot study from a birth cohort study. J Diabetes Investig 8(4):550–553CrossRefGoogle Scholar
  11. 11.
    Hu H, Li L, Guo Q et al (2016) A mechanistic study to increase understanding of titanium dioxide nanoparticles-increased plasma glucose in mice. Food Chem Toxicol 95:175–187CrossRefGoogle Scholar
  12. 12.
    Weir A, Westerhoff P, Fabricius L et al (2012) Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 46(4):2242–2250CrossRefGoogle Scholar
  13. 13.
    Auttachoat W, McLoughlin CE, White KL et al (2014) Route-dependent systemic and local immune effects following exposure to solutions prepared from titanium dioxide nanoparticles. J Immunotoxicol 11(3):273–282CrossRefGoogle Scholar
  14. 14.
    Haas BJ, Gevers D, Earl AM et al (2011) Chimeric 16S rRNA sequence formation and detection in sanger and 454-pyrosequenced PCR amplicons. Genome Res 21(3):494–504CrossRefGoogle Scholar
  15. 15.
    Fadrosh DW, Ma B, Gajer P et al (2014) An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2(1):6CrossRefGoogle Scholar
  16. 16.
    Gu N, Hu H, Guo Q et al (2015) Effects of oral administration of titanium dioxide fine-sized particles on plasma glucose in mice. Food Chem Toxicol 86:124–131CrossRefGoogle Scholar
  17. 17.
    Yang Y, Doudrick K, Bi X et al (2014) Characterization of food-grade titanium dioxide: the presence of nanosized particles. Environ Sci Technol 48:6391–6400CrossRefGoogle Scholar
  18. 18.
    Chen XX, Cheng B, Yang YX et al (2013) Characterization and preliminary toxicity assay of nano-titanium dioxide additive in sugar-coated chewing gum. Small 9:1765–1774CrossRefGoogle Scholar
  19. 19.
    Xie Y, Liu D, Cai C et al (2016) Size-dependent cytotoxicity of Fe3O4 nanoparticles induced by biphasic regulation of oxidative stress in different human hepatoma cells. Int J Nanomedicine 11:3557–3570CrossRefGoogle Scholar
  20. 20.
    Kuang H, Yang P, Yang L et al (2016) Size dependent effect of ZnO nanoparticles on endoplasmic reticulum stress signaling pathway in murine liver. J Hazard Mater 317:119–126CrossRefGoogle Scholar
  21. 21.
    Khan I, Azhar EI, Abbas AT et al (2016) Metagenomic analysis of antibiotic-induced changes in gut microbiota in a pregnant rat model. Front Pharmacol 7:104Google Scholar
  22. 22.
    Labrecque MT, Malone D, Caldwell KE et al (2015) Impact of ethanol and saccharin on fecal microbiome in pregnant and non-pregnant mice. J Pregnancy Child Health 2(5):1000193CrossRefGoogle Scholar
  23. 23.
    Peck BCE, Seeley RJ (2018) How does ‘metabolic surgery’ work its magic? New evidence for gut microbiota. Curr Opin Endocrinol Diabetes Obes 25(2):81–86Google Scholar
  24. 24.
    Cauci S, Driussi S, De Santo D et al (2002) Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J Clin Microbiol 40:2147–2152CrossRefGoogle Scholar
  25. 25.
    Yu Q, Jia A, Li Y et al (2018) Microbiota regulate the development and function of the immune cells. Int Rev Immunol 37(2):79–89CrossRefGoogle Scholar
  26. 26.
    Franasiak JM, Scott RT (2017) Contribution of immunology to implantation failure of euploid embryos. Fertil Steril 107:1279–1283CrossRefGoogle Scholar
  27. 27.
    Al Khodor S, Reichert B, Shatat IF (2017) The microbiome and blood pressure: can microbes regulate our blood pressure? Front Pediatr 5:138CrossRefGoogle Scholar
  28. 28.
    Kumar R, Herold JL, Schady D et al (2017) Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development. PLoS Pathog 13:e1006440CrossRefGoogle Scholar
  29. 29.
    Isolauri E, Rautava S, Collado MC et al (2015) Role of probiotics in reducing the risk of gestational diabetes. Diabetes Obes Metab 17:713–719CrossRefGoogle Scholar
  30. 30.
    Yan X, Feng B, Li P et al (2016) Microflora disturbance during progression of glucose intolerance and effect of Sitagliptin: an animal study. J Diabetes Res 2016:2093171Google Scholar
  31. 31.
    Wang G, Li X, Zhao J et al (2017) Lactobacillus casei CCFM419 attenuates type 2 diabetes via a gut microbiota dependent mechanism. Food Funct 8(9):3155–3164CrossRefGoogle Scholar
  32. 32.
    Tsuchiya Y, Kawamata K (2017) Effects of taurine on plasma glucose concentration and active glucose transport in the small intestine. Anim Sci J 88(11):1763–1767CrossRefGoogle Scholar
  33. 33.
    Yu X, Zhao X, Ze Y et al (2014) Changes of serum parameters of TiO(2) nanoparticle-induced atherosclerosis in mice. J Hazard Mater 280:364–371CrossRefGoogle Scholar
  34. 34.
    Capobianco E, Fornes D, Linenberg I et al (2016) A novel rat model of gestational diabetes induced by intrauterine programming is associated with alterations in placental signaling and fetal overgrowth. Mol Cell Endocrinol 422:221–232CrossRefGoogle Scholar
  35. 35.
    Kawasaki M, Arata N, Miyazaki C et al (2018) Obesity and abnormal glucose tolerance in offspring of diabetic mothers: a systematic review and meta-analysis. PLoS One 13:e0190676CrossRefGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Zhilei Mao
    • 1
    • 2
    • 3
  • Yaqi Li
    • 2
    • 3
  • Tianyu Dong
    • 2
    • 3
  • Lina Zhang
    • 1
  • Yuqing Zhang
    • 2
    • 3
  • Shushu Li
    • 2
    • 3
  • Haiting Hu
    • 1
  • Caifeng Sun
    • 1
    Email author
  • Yankai Xia
    • 2
    • 3
    Email author
  1. 1.Changzhou Maternity and Child Health Care Hospital affiliated to Nanjing Medical UniversityChangzhouChina
  2. 2.State Key Laboratory of Reproductive MedicineInstitute of Toxicology, Nanjing Medical UniversityNanjingChina
  3. 3.Key Laboratory of Modern Toxicology of Ministry of Education, School of Public HealthNanjing Medical UniversityNanjingChina

Personalised recommendations